Quality of life of hypertensive patients treated at an outpatient clinic;Qualidade de vida de pacientes hipertensos em tratamento ambulatorial

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 4, 2007, Pages 245-250

  Cavalcante, Margaret Assad ^a,b   Bombig, Maria Teresa Nogueira ^a   Luna Filho, Braulio ^a   Carvalho, Antonio Carlos De Camargo ^a   De Paola, Angelo A V ^a   Póvoa, Rui ^a  

^a UNIVERSIDADE DO OESTE PAULISTA UNOESTE   (Brazil)

^b NONE   (Brazil)

Author keywords

Hypertension therapy; Outpatients; Quality of life; Questionnaires

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE STUDY; CHI SQUARE TEST; CHRONIC DISEASE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA ANALYSIS; DEMOGRAPHY; EMOTION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; SEXUAL BEHAVIOR; SEXUALITY; SHORT FORM 36; STUDENT T TEST; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NFI TRANSCRIPTION FACTORS; OUTPATIENT CLINICS, HOSPITAL; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; SEXUALITY; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 37349058914     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Williams GH. Assessing patients' wellness: new perspectives on quality of life and compliance. Am J Hypertens. 1998; 11 (11 Pt 2): 186S-191S.
2. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group Psychol Med. 1998; 28 (3): 551-8.
3. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality of life instruments. Pharmacoeconomics. 2000; 17 (1): 13-35.
4. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989; 24: S217-S232.
5. Baar JT. The outcomes movement and health status measures. J Allied Health. 1995; 24: 13-28.
6. Guyatt GH. A taxonomy of health status instruments. J Rheumatol. 1995; 22: 1188-90.
7. Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA. 1997; 277 (15): 1232-7.
8. Bardage C, Isacson D, Ring L, Bingefors K. A Swedish population-based study on the relationship between the SF-36 and health utilities to measure health in hypertension. Blood Press. 2003; 12 (4): 203-10.
9. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992; 30: 473-83.
10. Ware JE, Gandek B. The SF-36 health survey: development and use in mental health research and the IQOLA project. Int Ment Health. 1994; 23: 49-73.
11. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma RM. Brazilian-portuguese version of SF-36: a reliable and valid quality of life outcome measure. Rev Bras Reumatol. 1999; 39: 143-50.
12. Horwitz RI, Horwitz SM. Adherence to the treatment and health outcomes. Arch Intern Med. 1993; 153: 1863-8.
13. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992; 305: 160-4.
14. Perneger TV, Leplége A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short-Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol. 1995; 48: 1051-60.
15. Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 Health Survey - I Evaluation of data quality, scaling assumptions, reliability and construct validity across general population in Sweden. Soc Sci Med. 1995; 41 (10): 1349-58.
16. Alderman MH. Quality of life in hypertensive patients: does it matter and should we measure it? J Hypertens. 2005; 23: 1635-6.
17. Roca-Cusachs A, Dalfo A, Badia X, Aristegui I, Roset M. Relation between clinical and therapeutic variables and quality of life in hypertension. J Hypertens. 2001; 19 (10): 1913-9.
18. Li W, Liu L, Puente JG, Li Y, Jiang X, Jin S, et al. Hypertension and health related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens. 2005; 23 (9): 1667-76.
19. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased abseenteism from work after detection and labeling of hipertensive patients. N Engl J Med. 1978; 299 (14): 741-4.
20. Bulpitt CJ, Fletcher A. Importance of well-being to hypertensive patients. Am J Med. 1988; 84 (1B): 40-6.
21. Alderamn MH, Lamport B. Labelling of hipertensives. J Clin Epidemiol. 1990; 43: 195-200.
22. Krousel-Wood MA, Re RN. Health status assessment in a hypertension section of an internal medicine clinic. Am J Med Sci. 1994; 308: 211-7.
23. Cade NV. Terapia de grupo para pacientes com hipertensão arterial. Rev Psiq Clin. 2001; 28: 300-4.
24. Lyons RA, Lo SV, Littlepage BN. Comparative health status of patients with 11 common illness in Wales. J Epidemiol Community Health. 1994; 48 (4): 388-90.
25. Battersby C, Hartley K, Fletcher AE, Markowe HJ, Styles W, Sapper H, et al. Quality of life in treated hypertension: a case-control community based study. J Hum Hypertens. 1995; 9 (12): 981-6.
26. Chan-Huang I, Albert WU, Constantine F. Do the SF-36 and WHOQOL-BREF measure the same construct? Evidence from the Taiwan population. Qual Life Res. 2006; 15: 15-24.